Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway - Trial NCT04663386
Access comprehensive clinical trial information for NCT04663386 through Pure Global AI's free database. This phase not specified trial is sponsored by Orion Corporation, Orion Pharma and is currently Terminated. The study focuses on Asthma,COPD. Target enrollment is 29 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Orion Corporation, Orion Pharma
Timeline & Enrollment
N/A
Dec 10, 2020
Sep 14, 2021
Primary Outcome
Disease control
Summary
This is a retrospective, multicentre, non-interventional, observational study in patients
 with asthma and/or COPD who are treated with budesonide-formoterol.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04663386
Non-Device Trial